Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2022 · 10-Q
Revenue$91.39M$91.39M+72.6% vs Q2 2021 Net Income-$14.49M-$14.49MN/M vs Q2 2021 EPS Diluted-$0.53-$0.53N/M vs Q2 2021 Gross Profit$77,213,000+69.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,954,000N/M Free Cash Flowderived-$7,373,000N/M Margins · derivedGross margin84.5%−1.3 pt vs Q2 2021
Operating margin-15.3%+8.4 pt vs Q2 2021
Net margin-15.9%+8.9 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 2, 2022 · 33 d after period end